Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Author Correction: The landscape of genomic alterations across childhood cancers.

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM; ICGC PedBrain-Seq Project; ICGC MMML-Seq Project.

Nature. 2018 Jul;559(7714):E10. doi: 10.1038/s41586-018-0167-2.

PMID:
29875405
2.

Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma.

Schober SJ, von Luettichau I, Wawer A, Steinhauser M, Salat C, Schwinger W, Ussowicz M, Antunovic P, Castagna L, Kolb HJ, Burdach SEG, Thiel U.

Oncotarget. 2018 Apr 27;9(32):22741-22748. doi: 10.18632/oncotarget.25228. eCollection 2018 Apr 27.

3.

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy.

Weidenbusch B, Richter GHS, Kesper MS, Guggemoos M, Gall K, Prexler C, Kazantsev I, Sipol A, Lindner L, Nathrath M, Witt O, Specht K, Beitinger F, Knebel C, Hosie S, von Eisenhardt-Rothe R, Weichert W, Luettichau IT, Burdach S.

Oncotarget. 2018 Apr 17;9(29):20747-20760. doi: 10.18632/oncotarget.25087. eCollection 2018 Apr 17.

4.

Impact of Pathological Fractures on the Prognosis of Primary Malignant Bone Sarcoma in Children and Adults: A Single-Center Retrospective Study of 205 Patients.

Schlegel M, Zeumer M, Prodinger PM, Woertler K, Steinborn M, von Eisenhart-Rothe R, Burdach S, Rechl H, von Luettichau I.

Oncology. 2018;94(6):354-362. doi: 10.1159/000487142. Epub 2018 Apr 13.

PMID:
29656296
5.

[Transient Pseudohypoaldosteronism - an Important Differential Diagnosis to Congenital Adrenal Hyperplasia].

Metz J, Kesper MS, Uetz B, Burdach S, Warncke K.

Klin Padiatr. 2018 Jul;230(4):229-230. doi: 10.1055/a-0575-4068. Epub 2018 Mar 21. German. No abstract available.

PMID:
29564839
6.

The landscape of genomic alterations across childhood cancers.

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H; ICGC PedBrain-Seq Project; ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg CM, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM.

Nature. 2018 Mar 15;555(7696):321-327. doi: 10.1038/nature25480. Epub 2018 Feb 28. Erratum in: Nature. 2018 Jun 6;:.

PMID:
29489754
7.

Cell death-based treatment of childhood cancer.

Westhoff MA, Marschall N, Grunert M, Karpel-Massler G, Burdach S, Debatin KM.

Cell Death Dis. 2018 Jan 25;9(2):116. doi: 10.1038/s41419-017-0062-z. Review.

8.

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL.

Locatelli F, Valsecchi MG, Möricke A, Zimmermann M, Gruhn B, Biondi A, Kulozik AE, Silvestri D, Bodmer N, Putti MC, Burdach S, Micalizzi C, Teigler-Schlegel A, Ritter J, Pession A, Cario G, Bielack S, Basso G, Klingebiel T, Vinti L, Rizzari C, Attarbaschi A, Santoro N, Parasole R, Mann G, Karawajew L, Haas OA, Conter V, Schrappe M.

Blood. 2017 Nov 9;130(19):2146-2149. doi: 10.1182/blood-2017-05-782086. Epub 2017 Sep 22. No abstract available.

PMID:
28939722
9.

Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.

Thiel U, Schober SJ, Einspieler I, Kirschner A, Thiede M, Schirmer D, Gall K, Blaeschke F, Schmidt O, Jabar S, Ranft A, Alba Rubío R, Dirksen U, Grunewald TGP, Sorensen PH, Richter GHS, von Lüttichau IT, Busch DH, Burdach SEG.

Oncoimmunology. 2017 Apr 12;6(5):e1312239. doi: 10.1080/2162402X.2017.1312239. eCollection 2017.

10.

Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma in vitro and in vivo.

Kirschner A, Thiede M, Grünewald TG, Alba Rubio R, Richter GH, Kirchner T, Busch DH, Burdach S, Thiel U.

Oncoimmunology. 2017 Jan 17;6(2):e1273301. doi: 10.1080/2162402X.2016.1273301. eCollection 2017.

11.

The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.

von Heyking K, Calzada-Wack J, Göllner S, Neff F, Schmidt O, Hensel T, Schirmer D, Fasan A, Esposito I, Müller-Tidow C, Sorensen PH, Burdach S, Richter GHS.

Mol Oncol. 2017 Sep;11(9):1288-1301. doi: 10.1002/1878-0261.12057. Epub 2017 Aug 21.

12.

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity.

Herzog J, von Klot-Heydenfeldt F, Jabar S, Ranft A, Rossig C, Dirksen U, Van den Brande J, D'Incalci M, von Luettichau I, Grohar PJ, Berdel WE, Burdach S.

Sarcoma. 2016;2016:7461783. Epub 2016 Oct 24.

13.

Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center.

Warncke K, Falco F, Rabl W, Engelsberger I, Saier J, Flores-Rodriguez D, Burdach S, Bonfig W.

J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1187-1194. doi: 10.1515/jpem-2016-0103.

PMID:
27682711
14.

Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.

Thiel U, Wawer A, von Luettichau I, Bender HU, Blaeschke F, Grunewald TG, Steinborn M, Röper B, Bonig H, Klingebiel T, Bader P, Koscielniak E, Paulussen M, Dirksen U, Juergens H, Kolb HJ, Burdach SE.

Oncotarget. 2016 Oct 25;7(43):70959-70968. doi: 10.18632/oncotarget.10938.

15.

Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Schirmer D, Grünewald TG, Klar R, Schmidt O, Wohlleber D, Rubío RA, Uckert W, Thiel U, Bohne F, Busch DH, Krackhardt AM, Burdach S, Richter GH.

Oncoimmunology. 2016 Apr 25;5(6):e1175795. doi: 10.1080/2162402X.2016.1175795. eCollection 2016 Jun.

16.

Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.

Kirschner A, Thiede M, Blaeschke F, Richter GH, Gerke JS, Baldauf MC, Grünewald TG, Busch DH, Burdach S, Thiel U.

Oncotarget. 2016 Aug 30;7(35):56584-56597. doi: 10.18632/oncotarget.10647.

17.

The posterior HOXD locus: Its contribution to phenotype and malignancy of Ewing sarcoma.

von Heyking K, Roth L, Ertl M, Schmidt O, Calzada-Wack J, Neff F, Lawlor ER, Burdach S, Richter GH.

Oncotarget. 2016 Jul 5;7(27):41767-41780. doi: 10.18632/oncotarget.9702.

18.

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.

Blaeschke F, Thiel U, Kirschner A, Thiede M, Rubio RA, Schirmer D, Kirchner T, Richter GHS, Mall S, Klar R, Riddell S, Busch DH, Krackhardt A, Grunewald TG, Burdach S.

Oncotarget. 2016 Jul 12;7(28):43267-43280. doi: 10.18632/oncotarget.9218.

19.

The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.

Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, Dirksen U, van der Ent W, Grohar P, Grünewald TG, Helman L, Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou T, Radic Sarikas B, Rédini F, Richter GH, Rossig C, Schadler K, Schäfer BW, Scotlandi K, Sheffield NC, Shelat A, Snaar-Jagalska E, Sorensen P, Stegmaier K, Stewart E, Sweet-Cordero A, Szuhai K, Tirado OM, Tirode F, Toretsky J, Tsafou K, Üren A, Zinovyev A, Delattre O.

Oncotarget. 2016 Feb 23;7(8):8613-24. doi: 10.18632/oncotarget.6937. Review.

20.

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.

Kovac M, Blattmann C, Ribi S, Smida J, Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M, Krieg A, Andreou D, Tunn PU, Dürr HR, Rechl H, Schaser KD, Melcher I, Burdach S, Kulozik A, Specht K, Heinimann K, Fulda S, Bielack S, Jundt G, Tomlinson I, Korbel JO, Nathrath M, Baumhoer D.

Nat Commun. 2015 Dec 3;6:8940. doi: 10.1038/ncomms9940.

21.

Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.

Hensel T, Giorgi C, Schmidt O, Calzada-Wack J, Neff F, Buch T, Niggli FK, Schäfer BW, Burdach S, Richter GH.

Oncotarget. 2016 Jan 12;7(2):1451-63. doi: 10.18632/oncotarget.6385.

22.

Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.

Agelopoulos K, Richter GH, Schmidt E, Dirksen U, von Heyking K, Moser B, Klein HU, Kontny U, Dugas M, Poos K, Korsching E, Buch T, Weckesser M, Schulze I, Besoke R, Witten A, Stoll M, Köhler G, Hartmann W, Wardelmann E, Rossig C, Baumhoer D, Jürgens H, Burdach S, Berdel WE, Müller-Tidow C.

Clin Cancer Res. 2015 Nov 1;21(21):4935-46. doi: 10.1158/1078-0432.CCR-14-2744. Epub 2015 Jul 15.

23.

Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence?

Karastaneva A, Lanz S, Wawer A, Behrends U, Schindler D, Dietrich R, Burdach S, Urban C, Benesch M, Seidel MG.

Front Pediatr. 2015 Jun 8;3:50. doi: 10.3389/fped.2015.00050. eCollection 2015.

24.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
25.

Targeting the EWS-FLI1 transcription factor in Ewing sarcoma.

Tancredi R, Zambelli A, DaPrada GA, Fregoni V, Pavesi L, Riccardi A, Burdach S, Grohar PJ, D'Incalci M.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1317-20. doi: 10.1007/s00280-015-2726-7. Epub 2015 Mar 26.

PMID:
25809543
26.

Indoleamine-2,3-dioxygenase in an immunotherapy model for Ewing sarcoma.

Max D, Kühnöl CD, Burdach S, Niu L, Staege MS, Föll JL.

Anticancer Res. 2014 Nov;34(11):6431-41.

PMID:
25368243
27.

Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.

Mauz-Körholz C, Hasenclever D, Holzendorf V, Bernstädt M, Jürgens H, Burdach S, Eggert A, Berthold F, Müller HL, Frühwald MC, Klingebiel T, Metzler M, Körholz D.

Leuk Lymphoma. 2015 May;56(5):1308-14. doi: 10.3109/10428194.2014.961011. Epub 2014 Oct 9.

PMID:
25204374
28.

Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation.

Reinwald M, Schleyer E, Kiewe P, Blau IW, Burmeister T, Pursche S, Neumann M, Notter M, Thiel E, Hofmann WK, Kolb HJ, Burdach S, Bender HU.

Biomed Res Int. 2014;2014:637059. doi: 10.1155/2014/637059. Epub 2014 Jun 15.

29.

[Associations with ADHD and parental distress with in play in early childhood].

Weber-Börgmann I, Burdach S, Barchfeld P, Wurmser H.

Z Kinder Jugendpsychiatr Psychother. 2014 May;42(3):147-55. doi: 10.1024/1422-4917/a000284. German.

PMID:
24846863
30.

Severe pretreatment cerebral edema in newly diagnosed type 1 diabetes.

Warncke K, Dressel P, Ziegler AG, Steinborn M, Bonfig W, Burdach S, Engelsberger I.

Horm Res Paediatr. 2014;81(4):285-8. doi: 10.1159/000357140. Epub 2014 Mar 13.

PMID:
24642459
31.

Molecular precision chemotherapy: overcoming resistance to targeted therapies?

Burdach S.

Clin Cancer Res. 2014 Mar 1;20(5):1064-6. doi: 10.1158/1078-0432.CCR-13-3194. Epub 2014 Feb 17.

32.

Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment.

Thiel U, Koscielniak E, Blaeschke F, Grunewald TG, Badoglio M, Diaz MA, Paillard C, Prete A, Ussowicz M, Lang P, Fagioli F, Lutz P, Ehninger G, Schneider P, Santucci A, Bader P, Gruhn B, Faraci M, Antunovic P, Styczynski J, Krüger WH, Castagna L, Rohrlich P, Ouachée-Chardin M, Salmon A, Peters C, Bregni M, Burdach S; Solid Tumour Working Party and the Paediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.

Br J Cancer. 2013 Nov 12;109(10):2523-32. doi: 10.1038/bjc.2013.630. Epub 2013 Oct 22.

33.

Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial.

Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, Schatz D, Atkinson M, Haller MJ, Egger D, Burdach S, Ziegler AG.

Pediatr Diabetes. 2014 Mar;15(2):100-9. doi: 10.1111/pedi.12072. Epub 2013 Sep 19.

PMID:
24102806
34.

The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.

Grunewald TG, Willier S, Janik D, Unland R, Reiss C, Prazeres da Costa O, Buch T, Dirksen U, Richter GH, Neff F, Burdach S, Butt E.

Biol Cell. 2013 Nov;105(11):535-47. doi: 10.1111/boc.201300041. Epub 2013 Sep 18.

PMID:
24033704
35.

The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?

Burdach S, Kolb HJ.

Front Oncol. 2013 May 3;3:100. doi: 10.3389/fonc.2013.00100. eCollection 2013.

36.

First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications.

Miller IV, Raposo G, Welsch U, Prazeres da Costa O, Thiel U, Lebar M, Maurer M, Bender HU, von Luettichau I, Richter GH, Burdach S, Grunewald TG.

Biol Cell. 2013 Jul;105(7):289-303. doi: 10.1111/boc.201200086. Epub 2013 May 4.

PMID:
23521563
37.

Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.

Bauer F, Filipiak-Pittroff B, Wawer A, von Luettichau I, Burdach S.

Pediatr Hematol Oncol. 2013 May;30(4):263-72. doi: 10.3109/08880018.2013.777948. Epub 2013 Mar 19.

PMID:
23509879
38.

Recurrent hypoglycemia due to growth hormone deficiency in an infant with Turner syndrome.

Bonfig W, Salem NJ, Heiliger K, Hempel M, Lederer G, Bornkamm M, Wieland K, Lohse P, Burdach S, Oexle K.

J Pediatr Endocrinol Metab. 2012;25(9-10):991-5. doi: 10.1515/jpem-2012-0103.

PMID:
23426831
39.

G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1.

Richter GH, Fasan A, Hauer K, Grunewald TG, Berns C, Rössler S, Naumann I, Staege MS, Fulda S, Esposito I, Burdach S.

J Pathol. 2013 May;230(1):70-81. doi: 10.1002/path.4170. Epub 2013 Mar 14.

PMID:
23338946
40.

DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.

Hauer K, Calzada-Wack J, Steiger K, Grunewald TG, Baumhoer D, Plehm S, Buch T, Prazeres da Costa O, Esposito I, Burdach S, Richter GH.

Cancer Res. 2013 Jan 15;73(2):967-77. doi: 10.1158/0008-5472.CAN-12-1492. Epub 2012 Nov 30.

41.

[Congenital vascular malformations].

Stiegler H, Hosie S, Burdach S, Hahn H, Saleh A, Brandl R, Lauen J.

MMW Fortschr Med. 2012 Oct 18;154(18):51-4, 56. Review. German. No abstract available.

PMID:
23156876
42.

Adrenal crisis caused by inhaled fluticasone in an adolescent with cystic fibrosis and advanced hepatopathy: a case report.

Denne C, Vogl-Voswinckel AE, Gruebl A, Burdach S.

Case Rep Pulmonol. 2012;2012:913574. doi: 10.1155/2012/913574. Epub 2012 Sep 29.

43.

Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).

Haase R, Vilser C, Mauz-Körholz C, Hasenclever D, Kluge R, Ruschke K, Borkhardt A, Seeger K, Lehrnbecher T, Kulozik A, Rößler J, Burdach S, Jürgens H, Körholz D.

Klin Padiatr. 2012 Oct;224(6):377-81. doi: 10.1055/s-0032-1323824. Epub 2012 Oct 9.

PMID:
23047832
44.

Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma.

Thiel U, Wolf P, Wawer A, Blaeschke F, Grunewald TG, von Lüttichau IT, Klingebiel T, Bader P, Borkhardt A, Laws HJ, Handgretinger R, Lang P, Schlegel PG, Eyrich M, Gruhn B, Ehninger G, Koscielniak E, Klein C, Sykora KW, Holler E, Mauz-Körholz C, Woessmann W, Richter GH, Schmidt AH, Peters C, Dirksen U, Jürgens H, Bregni M, Burdach S.

Klin Padiatr. 2012 Oct;224(6):353-8. doi: 10.1055/s-0032-1321730. Epub 2012 Jul 20.

PMID:
22821288
45.

MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival.

Wernicke CM, Richter GH, Beinvogl BC, Plehm S, Schlitter AM, Bandapalli OR, Prazeres da Costa O, Hattenhorst UE, Volkmer I, Staege MS, Esposito I, Burdach S, Grunewald TG.

Leuk Res. 2012 Sep;36(9):1185-92. doi: 10.1016/j.leukres.2012.05.009. Epub 2012 Jun 29.

PMID:
22748921
46.

The first European interdisciplinary ewing sarcoma research summit.

Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, Riedmann LT, Rossig C, Schäfer BW, Schwentner R, Scotlandi K, Sorensen PH, Staege MS, Tirode F, Toretsky J, Ventura S, Eggert A, Ladenstein R.

Front Oncol. 2012 May 29;2:54. doi: 10.3389/fonc.2012.00054. eCollection 2012.

47.

[Atypical course of pneumonia, a case report].

Denne C, Grübl A, Steinborn M, Burdach S.

MMW Fortschr Med. 2012 Apr 5;154(6):68-9. German. No abstract available.

PMID:
22642034
48.

Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literature.

Grunewald TG, Greulich N, Kontny U, Frühwald M, Rutkowski S, Kordes U, Scheurlen W, Schmidt W, Stachel D, Metzler M, Mittler U, Graf N, Benesch M, Burdach S.

Klin Padiatr. 2012 Apr;224(3):124-31. doi: 10.1055/s-0032-1301930. Epub 2012 Apr 20. Review.

PMID:
22522984
49.

Avoiding harmful procedures in patients with elevated α-fetoprotein concentrations: hereditary persistence of α-fetoprotein is an important and benign differential diagnosis!

Bonfig W, Hempel M, Teichert-von Lüttichau I, Liptay S, Burdach S.

J Pediatr Hematol Oncol. 2012 Oct;34(7):e301-3.

PMID:
22430587
50.

High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients.

Grunewald TG, Ranft A, Esposito I, da Silva-Buttkus P, Aichler M, Baumhoer D, Schaefer KL, Ottaviano L, Poremba C, Jundt G, Jürgens H, Dirksen U, Richter GH, Burdach S.

Ann Oncol. 2012 Aug;23(8):2185-90. doi: 10.1093/annonc/mdr605. Epub 2012 Feb 8.

PMID:
22317770

Supplemental Content

Loading ...
Support Center